
Choose from 5 options:
© Commonwealth of Australia 2001
ISBN 0 642-51896-3
This work is copyright. Apart from any use as permitted under the Copyright Act 1968 (Cwlth), no part may be reproduced by any process without written permission from AusInfo. Requests and inquiries concerning reproduction and rights should be directed to the Manager, Legislative Services, AusInfo, GPO Box 84, Canberra ACT 2601.
This assessment was carried out under the National Industrial Chemicals Notification and Assessment Scheme (NICNAS). This Scheme was established by the Industrial Chemicals (Notification and Assessment) Act 1989 (the Act), which came into operation on 17 July 1990.
The principal aim of NICNAS is to aid in the protection of people at work, the public and the environment from the harmful effects of industrial chemicals.
NICNAS assessments are carried out in conjunction with Environment Australia (EA) and the Therapeutic Goods Administration (TGA), which carry out the environmental and public health assessments, respectively.
NICNAS has two major programs: the assessment of the health and environmental effects of new industrial chemicals prior to importation or manufacture; and the other focussing on the assessment of chemicals already in use in Australia in response to specific concerns about their health/or environmental effects.
There is an established mechanism within NICNAS for prioritising and assessing the many thousands of existing chemicals in use in Australia. Chemicals selected for assessment are referred to as Priority Existing Chemicals.
This Priority Existing Chemical report has been prepared by the Director (Chemicals Notification and Assessment) in accordance with the Act. Under the Act manufacturers and importers of Priority Existing Chemicals are required to apply for assessment. Applicants for assessment are given a draft copy of the report and 28 days to advise the Director of any errors. Following the correction of any errors, the Director provides applicants and other interested parties with a copy of the draft assessment report for consideration. This is a period of public comment lasting for 28 days during which requests for variation of the report may be made. Where variations are requested the Director’s decision concerning each request is made available to each respondent and to other interested parties (for a further period of 28 days). Notices in relation to public comment and decisions made appear in the Commonwealth Chemical Gazette.
In accordance with the Act, publication of this report revokes the declaration of this chemical as a Priority Existing Chemical, therefore manufacturers and importers wishing to introduce this chemical in the future need not apply for assessment. However, manufacturers and importers need to be aware of their duty to provide any new information to NICNAS, as required under section 64 of the Act.
Copies of this and other Priority Existing Chemical reports are available from NICNAS either by using the prescribed application form at the back of this report, the website www.nicnas.gov.au or ordering directly from the following address:
Benzene (CAS No. 71-43-2) was declared a Priority Existing Chemical on 7 April 1998 in response to occupational and public health concerns.
Benzene occurs naturally in fossil fuels and is produced incidentally in the course of natural processes and human activities that involve the combustion of organic matter such as wood, coal and petroleum products. The main industrial use of benzene is as a starting material for the synthesis of other chemicals. Most benzene feedstock is imported, but some is manufactured at an Australian steelworks as a by-product of coal coking. Large quantities of benzene are produced during the refining of petroleum and retained as a component of petrol. Petrol vehicle emissions are the predominant source of benzene in the environment.
Benzene is volatile and water-soluble and is considered biodegradable. Its major release is to the atmosphere, where it will break down in a matter of weeks. Direct release to the aquatic compartment is expected to be minor and significant removal will occur from volatilisation. Benzene release to soil is likely to be marginal. Concentrations in aquatic systems are expected to be far lower than of concern and a low aquatic risk is predicted. Due to the low expected exposure, a low environmental risk to terrestrial organisms is predicted. The short atmospheric lifetime of benzene indicates concentrations will not occur at levels harmful to the atmosphere. While widespread transport within the troposphere is possible, the chemical is not expected to reach the stratosphere and therefore would not have an influence on global warming or ozone depletion.
In animals and humans, benzene is absorbed by all routes of exposure, although dermal absorption is limited by its rapid evaporation from the skin. It is metabolised in the liver and several other organs, including the bone marrow. The parent molecule is eliminated with exhaled air. The metabolites are excreted in the urine.
In animals, benzene is not highly acutely toxic. Chronic exposure can result in central nervous system depression, immunosuppression, bone marrow depression, degenerative lesions of the gonads, foetal growth retardation, damage to genetic material and solid tumours in several organs.
In humans, acute exposure to high concentrations of benzene vapours can result in irritation of the skin, eyes and respiratory system and in central nervous system depression. Chronic exposure can result in bone marrow depression and leukaemia, particularly acute myeloid leukaemia, and possibly an increased risk of non-Hodgkin’s lymphoma and multiple myeloma. Structural and numerical chromosome aberrations have been detected in peripheral blood cells of workers exposed to high levels of benzene. For bone marrow depression, the lowest observed adverse effect level in humans is 7.6 parts per million (ppm), based on minimal blood count changes in otherwise healthy workers. No threshold has been established for the genotoxic and carcinogenic effects of benzene. Epidemiological evidence indicates that the risk of leukaemia increases with exposure and is significantly elevated at cumulative exposures above 50 ppm-years, corresponding to an 8-hour time-weighted average exposure above 1.25 ppm over a working life of 40 years.
Chronic benzene toxicity has been attributed to the formation of reactive metabolites that appear to exert their toxic effect in combination, with no one metabolite accounting for all of the observed effects.
Benzene is currently listed in the NOHSC List of Designated Hazardous Substances with the following classification: ‘Flammable’, ‘Carcinogen, Category 1’ and ‘Toxic: Danger of serious damage to health by prolonged exposure through inhalation, in contact with skin and if swallowed’. Category 1 carcinogens are those substances known to be carcinogenic to humans. Based on the assessment of health effects, this report has concluded that benzene also meets the NOHSC Approved Criteria for Classifying Hazardous Substances for classification as a skin, eye and respiratory system irritant and as a mutagenic substance in Category 3.
The public is exposed to benzene through the inhalation of indoor, in-vehicle and outdoor air contaminated with the chemical through releases that predominantly derive from vehicle exhaust, petrol evaporation and tobacco smoke. The 24-hour average lifetime exposure in the Australian urban population is estimated at 5.2 parts per billion (ppb). It is one-fifth higher in passive smokers exposed to tobacco smoke at home, at work and in their cars (6.1 ppb) and almost three times as high (15.2 ppb) in the average smoker.
Benzene-induced bone marrow depression is not expected to present a significant public health risk. Based upon low-dose extrapolation of relevant quantitative risk estimates and the above-mentioned exposure estimate, the excess lifetime risk of benzene-induced leukaemia in the Australian urban population is estimated to be in the order of one case per 10,000 with increased risk in sensitive subpopulations or at higher exposure levels. However, the estimated excess risk is based on substantial uncertainties in the exposure assessment which should be validated through collection of monitoring data.
As benzene is an established human carcinogen for which no safe level of exposure has been established, it is recommended that any increase in public exposure be avoided and that measures be taken to reduce exposure where this is practicable. The establishment of a national ambient air benzene level would facilitate these objectives.
Occupational exposure to benzene is predominantly by the inhalation route. It occurs primarily in the petroleum, steel, chemical and associated industries and in laboratories using the chemical for research or analysis. Occupational exposure to benzene can also result from the contamination of workplace environments with petrol vapours, engine exhaust or tobacco smoke, for example, in vehicle mechanics, professional drivers and hospitality workers. It is estimated that current long-term occupational exposures to benzene are less than or equal to 0.7 ppm in the steel and associated industries and during maintenance of phenol plants; less than 0.1 ppm in the upstream petroleum industry (oil and gas production); less than 0.5 ppm in the chemical industry and in laboratory workers; less than 0.2 ppm in vehicle mechanics; less than 0.7 ppm in the downstream petroleum industry (refining, distribution and marketing of petroleum products); and less than 0.05 ppm in people who work in roadside or in-vehicle environments contaminated with vehicle exhaust or in indoor environments contaminated with tobacco smoke.
The occupational risk characterisation found no cause for concern about acute health effects or bone marrow depression, given the control measures which are already in place in Australian workplaces. However, there is cause for concern about the risk for leukaemia in all workers with repeated occupational exposure to benzene. There is no known threshold for the carcinogenic effects of benzene, but because the risk for leukaemia increases with exposure, it can be reduced by controlling exposure to the highest practicable standard.
With regard to occupational health and safety, it is recommended that the national exposure standard for benzene be revised. It is recommended that an eight-hour time-weighted average of 0.5 ppm be adopted. It is further recommended that the current hazard classification be amended to include classification as ‘Irritating to eyes, respiratory system and skin’ (risk phrase R36/37/38) and as a mutagenic substance in Category 3 (risk phrase R40: ‘Possible risks of irreversible effects, Mutagen Category 3’). Occupational exposures to benzene should be minimised by improving workplace control measures and by using the best available technology.
This report has identified the need to reduce public exposure to air benzene levels as much as practicable. Public health recommendations include measures to reduce indoor benzene levels, such as proper sealing of attached garages and minimising environmental tobacco smoke. In order to better characterise the risk to the public from benzene exposure, personal and ambient air monitoring is recommended and a national ambient air standard should be set.
The chemical benzene (CAS No. 71-43-2) was declared a Priority Existing Chemical for full assessment under the Industrial Chemicals (Notification and Assessment) Act 1989 on 7 April 1998. It was nominated by the public because of concerns about its human health effects and the adequacy of the current Australian occupational exposure standard.
The objectives of this assessment were to:
Consistent with the objectives, this report presents a summary and critical evaluation of relevant information relating to the potential health and environmental hazards from exposure to benzene. Relevant scientific data were submitted by the applicants listed in Section 3, obtained from published papers identified in a comprehensive literature search of several online databases up to December 2000, or retrieved from other sources such as the reports and resource documents prepared for the health surveillance program of the Australian Institute of Petroleum (AIP) and the Illawarra leukaemia cluster investigation. Due to the availability of several peer-reviewed overseas assessment reports, not all primary sources of data were evaluated. However, relevant studies published since the cited reviews were assessed on an individual basis.
The characterisation of health and environmental risks in Australia was based upon information on use patterns, product specifications, occupational exposure and emissions to the environment made available by applicants and relevant State authorities. Information to assist in the assessment was also obtained through site visits and telephone interviews. The site visits included two petroleum refineries, two petrol terminals, a steelworks, a coal tar distillery, a bulk liquid storage facility and three chemical plants.
During all stages of preparation, the report has been subject to internal peer review by NICNAS, Environment Australia (EA) and the Therapeutic Goods Administration (TGA). Selected parts of the report were also peer reviewed by Professor Tom Beer, CSIRO Atmospheric Research (Sections 8 and 15); Dr Stephen Corbett, New South Wales Department of Health (Section 11); Dr Andrea Hinwood, Department of Environmental Protection, Western Australia (Sections 9, 11 and 13); and Professor Martyn T. Smith, University of California (Sections 9 and 12).
Benzene is a naturally occurring, hazardous, volatile organic compound which is ubiquitous in the environment. It is formed from biomass under the impact of heat, pressure and geological time. As such, it is present in fossil fuels which may release it to air when unearthed and, in particular, when heated to combustion. Benzene is also a product of natural processes and human activities that involve the instantaneous thermal degradation of organic matter. These sources of entry include bush fires, crop residue and forest management burning, petroleum refining, petrol combustion, wood and charcoal fires, fumes from heated cooking oils, tobacco smoke, incense, and waste incineration. In addition, benzene enters the environment in emissions and waste streams from industrial processes and waste disposal facilities.
Benzene was first isolated in 1825 and gradually became widely used as a solvent and starting material for the synthesis of a number of organic chemicals (Folkins, 1984). Benzene also became recognised as a valuable constituent of petrol because of its antiknock properties and ability to increase the octane rating of automotive fuels.
Until World War II, benzene was isolated from light oil, which is a by-product of the carbonisation of coal to produce gas for heating or coke for the blast furnaces of the steel industry. Beginning in the 1930s, new catalytic and thermal processes for the production of aromatic hydrocarbons from crude oil were discovered and commercialised in the petroleum industry. With the advent of natural gas in the 1960s, worldwide coal gas production started to diminish. Simultaneously, the introduction of modern steel processing methods decreased coke production and made it attractive to burn the light oil as fuel rather than segregate it into benzene and other products. In consequence, the petroleum industry is now the predominant source of benzene.
In recent years, the use of benzene-containing solvents has been practically eliminated because of the toxicity of the chemical. Current worldwide consumption of benzene is 30-35 million metric tonnes (t) per annum, primarily as chemical feedstock in the production of large-scale intermediates such as ethyl benzene, cumene and cyclohexane (Chemistry & Industry News, 1996). This figure does not include benzene produced by the petroleum industry and retained as a petrol component.
Commercial low-grade qualities are sometimes referred to as benzol. Benzene is not to be confused with benzine, which is a mixture of several low-boiling hydrocarbons obtained in the distillation of petroleum.
Developments in Australia have followed the general pattern outlined above, albeit with a delay of 1-2 decades. The recovery of benzene from coal gas is now limited to the steelworks at Port Kembla in New South Wales and Whyalla in South Australia.
There are eight petroleum refineries in Australia: two in Brisbane and Sydney and one in Adelaide, Geelong, Melbourne and Perth. Since the 1970s, close to 100% of local demand for petrol has been met from crude which is low in aromatic fractions (Tresider, 1998). As such, all Australian petroleum refineries have processes in place to increase the content of aromatic hydrocarbons including benzene in their petrol blendstock. Petroleum-derived benzene feedstock for the chemical industry is not produced in Australia.
As of 1986, new petrol-driven cars had to be fitted with catalytic converters and use unleaded fuel. An Australian Standard for petrol for motor vehicles was established in 1990 and limited the benzene content to a maximum of 5% v/v (Standards Australia, 1990). In 1998, the average benzene content in Australian petrol was 2.9, 2.6 and 3.3% v/v in leaded petrol (LP), unleaded petrol (ULP) and premium unleaded petrol (PULP) respectively (AIP, 1998b). The Fuel Quality Standards Act 2000 enables the Commonwealth to make mandatory national quality standards for fuel supplied in Australia. Among others, these will include a maximum content of benzene in petrol of 1% v/v from January 1 2006. Meanwhile, Western Australia and Queensland have introduced regulations limiting the benzene content in petrol to 1% and 3.5% respectively (EA, 2000b).
In 1980, AIP contracted The University of Melbourne to set up an epidemiological health surveillance program called Health Watch. The program covers about 95% of the industry’s 18,000 employees in refineries, natural gas plants, distribution terminals and production sites. It consists of a prospective cohort study of all-cause mortality and cancer incidence, in addition to a case-control study of lympho-haematopoietic cancers and benzene exposure established in 1988 (Glass et al., 1998, 2000; Health Watch, 1998).
Air pollution became a major concern in the 1990s and prompted environment and health authorities from the Commonwealth, States and Territories to initiate several research projects into ambient air quality. Early results of this research resulted in the inclusion of benzene in the National Pollutant Inventory (NPI), which was established by the National Environment Protection Council (NEPC) in 1998. The NPI currently comprises 36 chemicals of health and environmental concern which must be reported to EA if the quantity used or handled per site exceeds a threshold limit, which for benzene is 10 t per year (EA, 1999b). More recently, the Australian and New Zealand Environment and Conservation Council contracted the Victorian Environment Protection Authority (EPA) to assess the available air level data and derive a risk-based rank order of hazardous air pollutants according to their priorities for further research (EPA Victoria, 1999). Based on a scoring system as well as on professional judgement, benzene came first among 15 chemicals recommended for general urban air monitoring. Benzene is also the subject of a publication in the series of National Environmental Health Forum Monographs, which are intended to provide plain language information about important, topical environmental health matters (Wadge & Salisbury, 1997). Current EA initiatives such as the Fuel Quality Review and Living Cities – Air Toxics Program both address a number of environmental aspects relating to benzene (EA, 2000a, 2000b).
Public concern about exposure to benzene reached a peak in 1996, when a cluster of leukaemia cases was identified in people living in the suburbs adjacent to the coke ovens and coal gas by-product plant at the Port Kembla steelworks. A committee reporting to the New South Wales Department of Health was set up to investigate the matter. It concluded that based on the available data, it was not possible to ascribe the cluster to a particular exposure (including benzene). The investigation produced several useful publications relating to benzene and the risk of leukaemia (ILISC, 1997; Westley-Wise et al, 1999).
Although there have been restrictions on the manufacture, handling, storage and use of benzene in Australia since 1978, this report represents the first comprehensive risk assessment by a national agency.
Benzene has been assessed by several overseas or international bodies involved in the review or evaluation of data pertaining to the health and/or environmental hazards posed by chemicals. Of these, the most noteworthy are:
Following the declaration of benzene as a Priority Existing Chemical, 21 companies or organisations applied for assessment of the chemical. The applicants supplied information on the properties, import and manufacturing quantities and uses of benzene and, in some cases, on occupational exposures and releases to the environment. In accordance with the Industrial Chemicals (Notification and Assessment) Act 1989, NICNAS provided the applicants with a draft copy of the report for comments during the corrections/variation phase of the assessment. The applicants were as follows:
Alltech Associates (Australia) Pty Ltd
PO Box 6005
Baulkham Hills NSW 2153
Australian Institute of Petroleum
GPO Box 279
Canberra ACT 2601
Australian Council of Trade Unions
393 Swanston Street
Melbourne VIC 3000
Australian Manufactures Workers Union
3/440 Elizabeth Street
Melbourne VIC 3000
Bio-Scientific Pty Ltd
PO Box 78
Gymea NSW 2227
BP Australia Holding Limited
360 Elizabeth St
Melbourne VIC 3000
Caltex Petroleum Australia Pty Ltd
19-29 Martin Pl
Sydney NSW 2000
Crown Scientific Pty Ltd
Private Mail Bag 4
Moorebank NSW 2170
Huntsman Chemical Company Australia Pty Ltd
PO Box 62
West Footscray VIC 3012
ICN Biomedicals Australasia
PO Box 187
Seven Hills NSW 2147
Whyalla Steelworks (OneSteel Manufacturing)
PO Box 21
Whyalla SA 5600
Koppers Coal Tar Products Pty Ltd
PO Box 23
Mayfield NSW 2304
Merck Pty Ltd
207 Colchester Rd
Kilsyth VIC 3137
Mobil Oil Australia Pty Ltd
417 St Kilda Rd
Melbourne VIC 3004
BHP Steel – Flat Products
PO Box 1854
Wollongong NSW 2505
Qenos Pty Ltd
Private Bag 3
Altona VIC 3018
Selby-Biolab
Private Bag 24
Mulgrave North VIC 3170
Sigma-Aldrich Pty Ltd
PO Box 970
Castle Hill NSW 2154
Terminals Pty Ltd
PO Box 268
Footscray VIC 3011
3M Australia Pty Ltd
PO Box 144
St Marys NSW 2760
Trafigura Fuels Australia Pty Ltd
Unit 2, 47 Epping Rd
North Ryde NSW 2113
Benzene
Benzene is listed on the Australian Inventory of Chemical Substances (AICS) as benzene.
CAS number – 71-43-2
EINECS number – 200-753-7
UN number – 1144
Annulene
Benzol(e)
Bicarburet of hydrogen
Carbon oil
Coal naphtha
Cyclohexatriene
Mineral naphtha
Motor benzol
Phenyl hydride
Pyrobenzol(e)
C6H6
78.11
Several different grades of benzene are commercially available. The principal impurities are toluene, xylenes and other hydrocarbons with boiling points similar to that of benzene. The higher the grade, the lower the content of thiophene (thiofuran) and other sulfur compounds, which foul many catalysts used in reactions of benzene (Fruscella, 1992). The specifications for two typical import grades and the benzene/toluene/xylenes (BTX) mixture produced at the Port Kembla steelworks are shown in Table 4.1.
Table 4.1: Raw material specifications for some commercially available benzene grades
Test | Pure benzene | Crude benzene | BTX |
---|---|---|---|
Benzene (% v/v) | >99 | >=95 | >=80 |
C9 & higher (% v/v) | - | <1.5 | <1.6 |
Carbon disulfide (ppm) | - | <50 | <4000 |
H2S & SO2 | None | - | - |
Non-aromatic C5-C6 (% v/v) | <0.15 | <0.7 | <1.5 |
Styrene (% v/v) | - | - | <1.8 |
Thiophene (ppm) | <1 | <6000 | <6000 |
Toluene (% v/v) | - | - | <12.5 |
Total sulfur (ppm) | - | - | <6000 |
Xylenes & styrene (% v/v) | - | - | <3.8 |
ACGIH – American Conference of Governmental Industrial Hygienists
ADG – Australian Dangerous Goods
AIP – Australian Institute of Petroleum
ALC – absolute lymphocyte count
ALL – acute lymphatic leukaemia
AML – acute myeloid leukaemia
ANLL – acute non-lymphocytic leukaemia
atm – atmosphere
Avgas – light aircraft gasoline
BCF – bioconcentration factor
BP – benzene poisoning
BTX – benzene/toluene/xylenes
BW – body weight
C – centigrade
CAS – Chemical Abstracts Service
CFU-E – colony forming units of erythrocyte progenitor cells
CFU-M – colony forming units of granulocyte/macrophage progenitor cells
CI – confidence interval
CLL – chronic lymphatic leukaemia
cm – centimetre
cm2 – square centimetre
cm3 – cubic centimetre
CMA – Chemical Manufacturers Association
CML – chronic myeloid leukaemia
CNS – central nervous system
CSF – colony stimulating factor
CYP – mcytochrome-P450
DNA – deoxyribonucleic acid
EA – Environment Australia
EC50 – median effective concentration
EINECS – European Inventory of Existing Chemical Substances
EPA – Environment Protection Authority
ETS – environmental tobacco smoke
g – gram
GC – gas chromatography
GC-MS – gas chromatography-mass spectrometry
GD – gestation day
GLP – Good Laboratory Practices
GM-CSF – granulocyte/macrophage colony stimulating factor
GSH – glutathione
GST – glutathione-S-transferase
h – hour
ha – hectare
Hb – haemoglobin
Hct – haematocrit
IARC – International Agency for Research on Cancer
IL-1 – interleukin-1
IPCS – International Programme on Chemical Safety
IUCLID – International Uniform Chemical Information Database
IUPAC – International Union for Pure and Applied Chemistry
K – Kelvin
kg – kilogram
Km – Michaelis-Menten constant
km – kilometre
km2 – square kilometre
Koc – sorption coefficient
kPa – kilopascal
kt – kilotonne
L – litre
LC – lymphocyte
LC50 – median lethal concentration
LD50 – median lethal dose
LOAEL – lowest observed adverse effect level
LP – leaded petrol
LPG – liquid pressurised gas
m3 – cubic meter
MCV – mean corpuscular volume
MDS – myelodysplastic syndrome
mg – milligram
mL – millilitre
ML – megalitre
mM – millimolar
MM – multiple myeloma
MN – micronucleus
mol – mole
MSDS – material safety data sheet
NADPH – nicotinamide adenine dinucleotide phosphate
NEPC – National Environment Protection Council
NEPM – National Environment Protection Measures
ng – nanogram
NHIS – National Health Interview Survey
NHL – non-Hodgkin’s lymphoma
NICNAS – National Industrial Chemicals Notification and Assessment Scheme
NIOSH – National Institute of Occupational Safety and Health
nm – nanometre
nmol – nanomole
nM – nanomolar
NOAEL – no observed adverse effect level
NOEC – no observed effect concentration
NOHSC – National Occupational Health and Safety Commission
NPI – National Pollutant Inventory
NQO1 – NAD(P)H:quinone oxidoreductase
NSAID – non-steroidal anti-inflammatory drug
OECD – Organisation for Economic Co-Operation and Development
OR – odds ratio
OSHA – Occupational Safety and Health Administration
PAH – polycyclic aromatic hydrocarbon
PGE2 – prostaglandin E2
PKC – protein kinase C
Plt – blood platelet
PNEC – predicted no-effect concentration
Po/w – octanol/water partition coefficient
POP – persistent organic pollutant
ppb – parts per billion
PPE – personal protective equipment
ppm – parts per million
PULP – premium unleaded petrol
RBC – red blood cell (erythrocyte)
RNA – ribonucleic acid
RR – relative risk
s – second
SAb – spontaneous abortion
s-AML – secondary acute myeloid leukaemia
SC – subcutaneous
SCE – sister chromatid exchange
SGA – small-for-gestational age
SIR – standardised incidence rate
SMA – State marketing area
SMR – standardised mortality rate
STP – sewage treatment plant
SUSDP – Standard for the Uniform Scheduling of Drugs and Poisons
t – tonne
TGD – Technical Guidance Document
TWA – time-weighted average
TWA8 – 8-h time-weighted average
ULP – unleaded petrol
UN – United Nations
USEPA – United States Environmental Protection Agency
UTL95%,95% – upper tolerance limit of a distribution’s 95th percentile
v/v – volume/volume
VOC – volatile organic chemical
w/w – weight/weight
WBC – white blood cell (leukocyte)
WHO – World Health Organization
y – year
µg – microgram
µL – microlitre
µM – micromolar
µmol – micromole
8-OHdG – 8-hydroxydeoxyguanosine